Replimune (REPL) CMO Konstantinos Xynos Sells Shares

What Happened

• Konstantinos Xynos, Chief Medical Officer of Replimune Group, sold 11,447 shares of common stock on 2026-08-10 at $12.97 per share, generating proceeds of $148,468. The reported sale was made in connection with tax withholding obligations tied to the vesting of performance-based restricted stock units (PSUs).

Key Details

• Transaction date and price: 2026-08-10, 11,447 shares at $12.97 each (total $148,468).
• Transaction type: Sale (reported as "S"); described in the filing as a "sell-to-cover" to satisfy tax withholding on vested PSUs (Footnote F1).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Filing/timeliness: Report filed 2026-08-12 covering the 2026-08-10 transaction — appears to be filed within the normal two-business-day Form 4 window.

Context

• This was a routine sell-to-cover tied to tax obligations on vested performance awards, not a discretionary open-market sell aimed at raising cash or signaling sentiment. Such tax-withholding sales are common and generally less informative about an insider’s view of the company than voluntary purchases.